Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
Q4 2023 vs. Q3 2023
How the institutions holding Adma Biologics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 188 | 184 | −4 |
| Shares | 171.2M | 169.2M | −1.99M (−1.2%) |
| Value | $612.7M | $764.6M | +$151.9M (+24.8%) |
New holders (21)
Institutions that held Adma Biologics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jefferies Financial Group Inc. | 2,260,000 | $10.2M | 0.16% |
| Peregrine Capital Management LLC | 882,983 | $3.99M | 0.12% |
| Macquarie Group Ltd | 274,236 | $1.24M | 0.00% |
| Point72 Asset Management, L.P. | 244,513 | $1.11M | 0.00% |
| Wellington Management Group LLP | 213,985 | $967.2K | 0.00% |
| Occudo Quantitative Strategies LP | 198,821 | $898.7K | 0.12% |
| Deerfield Management Company, L.P. (Series C) | 42,657 | $192.8K | 0.00% |
| TownSquare Capital, LLC | 33,280 | $150.4K | 0.00% |
| Balyasny Asset Management LLC | 32,211 | $145.6K | 0.00% |
| Bailard, Inc. | 24,400 | $110.3K | 0.00% |
| Caxton Associates LP | 19,693 | $89.0K | 0.00% |
| Spouting Rock Asset Management, LLC | 18,399 | $83.2K | 0.03% |
| Oxford Asset Management LLP | 18,330 | $82.9K | 0.13% |
| AJOVista, LLC | 17,018 | $76.9K | 0.10% |
| Inspirion Wealth Advisors, LLC | 12,000 | $54.6K | 0.01% |
| Cynosure Management, LLC | 10,856 | $49.1K | 0.01% |
| Game Plan Financial Advisors, LLC | 1,000 | $4.52K | 0.00% |
| Adirondack Trust Co | 585 | $3.13K | 0.00% |
| GAMMA Investing LLC | 149 | $773 | 0.00% |
| The PNC Financial Services Group, Inc. | 25 | $113 | 0.00% |
| Farther Finance Advisors, LLC | 10 | $45 | 0.00% |
Sold out (25)
Institutions that held Adma Biologics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.